• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
AZD-7762 Hydrochloride

AZD-7762 Hydrochloride

Product ID A9912
Cas No. 1246094-78-9
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $75.00 In stock
5 mg $130.10 In stock
10 mg $204.40 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

AZD-7762 is an inhibitor of checkpoint kinase 1 (Chk1) that increases sensitivity to DNA-damaging compounds. AZD-7762 exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for a variety of cancers. In breast cancer and ovarian cancer cells, AZD-7762 inhibits cellular proliferation. In animal models of breast cancer, AZD-7762 inhibits tumor growth and increases survival rates. This compound displays somewhat limited efficacy due to cardiac toxicity.

Product Info

Cas No.

1246094-78-9

Purity

≥98%

Formula

C17H19FN4O2S • HCl

Formula Wt.

398.88

Synonym

AZD-7762 HCl

Solubility

DMSO 50 mg/mL (137.96 mM) Water Insoluble Ethanol Insoluble

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

A9912 MSDS PDF

Info Sheet

A9912 Info Sheet PDF

References

Bryant C, Rawlinson R, Massey AJ. Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers. BMC Cancer. 2014 Aug 7;14:570. PMID: 25104095.

Sausville E, Lorusso P, Carducci M, et al. Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors. Cancer Chemother Pharmacol. 2014 Mar;73(3):539-49. PMID: 24448638.

Ma CX, Cai S, Li S, et al. Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. J Clin Invest. 2012 Apr;122(4):1541-52. Erratum in: J Clin Invest. 2012 Jul 2;122(7):2702. PMID: 22446188.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C0016

    Caerulomycin A

    Bipyridamine toxin.
    ≥96%
  • K1978

    Ketorolac Tromethamine

    NSAID; COX-1/2 inhibitor.
    ≥98%
  • P7023

    Pregnenolone

    Endogenous precursor to all steroid hormones; TRPM...
    ≥98%
  • P4492

    PLX4720

    V600E B-Raf inhibitor.
    ≥98%
  • S7717

    Sterigmatocystin

    Mycotoxin produced by Aspergillus; carcinogen.
    ≥98%
  • H9613

    N-(4-Hydroxyphenyl)retinamide

    Retinol (vitamin A) analog, binds RBP4; Des1 inhib...
    ≥98%
  • K0030

    Kahweol

    Diterpene found in coffee beans.
    ≥97%
  • U8000

    U-74389G

    Antioxidant shown to improve renal function.
    ≥95%
  • V0245

    Valdecoxib

    NSAID; CB1 agonist, COX-2 inhibitor.
    ≥98%
  • W4096

    WKYMVM-NH2

    Synthetic peptide; FPRL1 agonist.
    ≥95%
  • M3410

    Microcystin (N-Me)-LR

    Cyclic heptapeptide produced by Microcystis; PP1/2...
    ≥95%
  • K0282

    Kavalactones Mixture

    Mixture of kavalactones found in Piper methysticum...
    ≥98%
  • F5869

    N-formyl-Met-Ala-Ser

    Peptide, involved in neutrophil activation; FPR1 a...
    ≥95%
  • Y0800

    YC-1

    Guanylyl cyclase activator and HIF-1α inhibitor.
    ≥98%
  • T3097

    Thymosin α-1 Acetate

    Endogenous peptide, involved in hormone regulation...
    ≥95%
  • G6803

    Granuliberin R

    Antimicrobial peptide found in amphibians.
    ≥95%
  • A5460

    A-type Natriuretic Peptide (1-11), rat

    Endogenous cardiomodulatory peptide; NPR-A agonist...
    ≥95%
  • S7061

    SRPIN340

    SRPK1 inhibitor.
    ≥98%
  • D3430

    Dihydrosanguinarine

    Benzophenanthridine alkaloid, sanguinarine metabol...
    ≥98%
  • C9880

    Cytochalasin C

    Mycotoxin produced by Aspergillus; actin polymeriz...
    ≥98%, TLC

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only